Exane Derivatives’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-20
Closed -$1.94K 684
2019
Q3
$1.94K Hold
20
﹤0.01% 463
2019
Q2
$2.05K Hold
20
﹤0.01% 481
2019
Q1
$2.28K Hold
20
﹤0.01% 410
2018
Q4
$783 Hold
20
﹤0.01% 540
2018
Q3
$1.09K Sell
20
-2,078
-99% -$114K ﹤0.01% 490
2018
Q2
$175K Hold
2,098
0.03% 253
2018
Q1
$136K Buy
+2,098
New +$136K 0.03% 252